Literature DB >> 10527809

The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia.

B Bondy1, M Spaeth, M Offenbaecher, K Glatzeder, T Stratz, M Schwarz, S de Jonge, M Krüger, R R Engel, L Färber, D E Pongratz, M Ackenheil.   

Abstract

Based on a possible involvement of serotonergic dysfunction in the pathophysiology of fibromyalgia (FM) and on preliminary reports of a possible genetically driven vulnerability for this disorder we investigated the silent T102C polymorphism of the 5-HT2A-receptor gene in 168 FM patients and 115 healthy controls. Our results showed a significantly different genotype distribution in FM patients with a decrease in T/T and an increase in both T/C and C/C genotypes as compared to the control population (Fisher's Exact test, two-sided, P = 0.008). However, the increase in allele-C102 frequency felt short of significance (P = 0.07). Correlation of genotypes to clinical parameters revealed no influences on age of onset, duration of disease or psychopathological symptoms, measured with the Beck Depression Inventory and the symptom checklist SCL-90-R. In contrast to that the pain score, being a self reported information on pain severity, was significantly higher in patients of the T/T genotype (Mann-Whitney U test, P = 0.028). This suggests that the T102-allele might be involved in the complex circuits of nociception. However, the T102C polymorphism is not directly involved in the aetiology of FM but might be in linkage dysequilibrium with the true functional variant, which has to be unravelled. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527809     DOI: 10.1006/nbdi.1999.0262

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  47 in total

Review 1.  Understanding fibromyalgia: lessons from the broader pain research community.

Authors:  David A Williams; Daniel J Clauw
Journal:  J Pain       Date:  2009-08       Impact factor: 5.820

2.  [Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].

Authors:  C Sommer; W Häuser; K Gerhold; P Joraschky; F Petzke; T Tölle; N Uçeyler; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 3.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

Review 4.  [Fibromyalgia--an update].

Authors:  W Brückle; H Zeidler
Journal:  Internist (Berl)       Date:  2005-11       Impact factor: 0.743

Review 5.  Candidate gene studies of fibromyalgia: a systematic review and meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

Review 6.  Pharmaceutical treatment options for fibromyalgia.

Authors:  Leslie J Crofford
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

7.  Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients.

Authors:  Bernd Frank; Beate Niesler; Brigitta Bondy; Michael Späth; Dieter E Pongratz; Manfred Ackenheil; Christine Fischer; Gudrun Rappold
Journal:  Clin Rheumatol       Date:  2004-05-07       Impact factor: 2.980

8.  Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: results from the EPIFUND study.

Authors:  Kate L Holliday; Gary J Macfarlane; Barbara I Nicholl; Francis Creed; Wendy Thomson; John McBeth
Journal:  J Psychosom Res       Date:  2010-05       Impact factor: 3.006

9.  The fibromyalgia family study: a genome-wide linkage scan study.

Authors:  Lesley M Arnold; Jinbo Fan; I Jon Russell; Muhammad B Yunus; Muhammad Asim Khan; Irving Kushner; Jane M Olson; Sudha K Iyengar
Journal:  Arthritis Rheum       Date:  2013-04

10.  Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels.

Authors:  Jinong Feng; Zhifang Zhang; Wenyan Li; Xiaoming Shen; Wenjia Song; Chunmei Yang; Frances Chang; Jeffrey Longmate; Claudia Marek; R Paul St Amand; Theodore G Krontiris; John E Shively; Steve S Sommer
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.